Fact CheckerSign in

NCT05457244Active, not recruiting

Safety and Performance of the da Vinci SP® Surgical System in Colorectal Procedures

A Prospective, Single-Center Investigation of the Safety and Performance of the da Vinci SP® Surgical System in Colorectal Procedures

Source: ClinicalTrials.gov · Last updated 20 Nov 2024

Brief summary (registry, in English)

The study is a prospective, single-center, single-arm unblinded clinical investigation. The aim of this study is to evaluate the performance and safety of da Vinci SP system. This study will entail a collection of demographics, preoperative, perioperative and postoperative outcomes of the patients into a database to follow this report on the outcomes, and notably answer questions to demonstrate the performance and safety of this surgical option. All patients being considered for minimally invasive colorectal surgery will be evaluated for participation in the above study. All of these patients will undergo a standard minimally invasive resection in the same fashion as would be carried out with multiport laparoscopic or robotic surgery

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
22 Jun 2022
Start date
1 Sept 2023
Primary completion date
19 Jun 2024
Lead sponsor
Chang Gung Memorial Hospital
NCT number
NCT05457244

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 1 Sept 2023 to the primary completion date, 19 Jun 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Emergency surgery
  • Previous laparotomy history

Other illness

  • Patient has metastatic disease
  • Patient has a bleeding or clotting disorder
  • Uncontrolled illness, including active infection, symptomatic heart failure, unstable angina or cardiac arrhythmias, or psychiatric illness that would limit compliance with study requirements

Other

  • Patient unable to provide informed consent
  • Patient is pregnant
  • BMI 35.0 or higher

Who the study is looking for

  • Age ≥18 years
  • Pathological confirm of colon or rectal cancer
  • Clinical stage I-III
  • Patient is a candidate for minimally invasive right hemicolectomy or anterior resection.
  • ASA ≤3
  • Performance status: ECOG 0-1

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kaohsiung Chang Gung Memorial Hospital
Coordinator of this site? Confirm its status
Kaohsiung CityTaiwanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.